Thanks. I also think that there will be maybe max. 200 subjects. No way they will need 1,000+ patients like sabaidii2 suggested.
If I remember correctly there are sometimes drug Trials which end with Phase 2b and the FDA agrees with that. Do you know in which cases this can happen? Can RXI apply for a pivotal Phase 2b trial?
SPA = Special Protocol Assessment. But doesn't matter. Question: Why are you talking about SPA? Did the Company ever say that they will make a request/apply for a SPA?
I have to say that you're absolutely right. But why, after this drama last time, why should they show new photos if again you don't see a difference? If they do this - I'll think about selling this stock.
I think some left after this brutal decline in the last months. Or maybe they are just waiting for news. People finally want to get some news, results. And the delays in recruitment didn't help the PPS but in the next few months there will be for sure at least some timeline so maybe the price will surge. If the results are good then the MCap has a lot of room to grow. It's like for example with RXII. People have to see some facts, good stuff, validation. And if we get this and if you look at the market potential, the we should at least be at $20 or even more. But with this small floats the PPS can do crazy things. Also to the upside.
I love this thumbs down! Please stand up and the one who gave me the thumb down can explain me thumb down for what? For information and facts?
I don't know how manEASL and possibly at AASLD until now but Linda said on the last CC that they plan to complete enrolment in mid-2015. But before before that there will be an interim analysis after 37 events have occurred.
Spain and NIH study: Data will be presented most likely at EASL (April 22 - 26) and possibly at AASLD.
From PR 09/18/2014: "The presentation will be available on the "Investors" section of the Company's website, ...."
By the way, everybody here on YMB had to post one day their first message. And don't be insulted if people here call you a soft basher when you ask critical questions. They are sensitive.